Rhythm Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell RYTM and other ETFs, options, and stocks.About RYTM
Rhythm Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with rare diseases. The firm offers IMCIVREE (setmelanotide), a precision medicine designed to treat hyperphagia and severe obesity caused by rare melanocortin-4 receptor (MC4R) diseases.
RYTM Key Statistics
Stock Snapshot
Rhythm Pharmaceuticals(RYTM) stock is priced at $92.39, giving the company a market capitalization of 6.31B. It carries a P/E multiple of -27.53.
On 2026-05-05, Rhythm Pharmaceuticals(RYTM) stock moved within a range of $90.00 to $99.00. With shares now at $92.39, the stock is trading +2.7% above its intraday low and -6.7% below the session's peak.
Trading volume for Rhythm Pharmaceuticals(RYTM) stock has reached 1.01M, versus its average volume of 602.39K.
Over the past 52 weeks, Rhythm Pharmaceuticals(RYTM) stock has traded between a high of $122.20 and a low of $55.31.
Over the past 52 weeks, Rhythm Pharmaceuticals(RYTM) stock has traded between a high of $122.20 and a low of $55.31.
RYTM News
Reports Q1 revenue $60.11M, consensus $56.07M. “The U.S and European approvals of IMCIVREE mark a transformational milestone for patients with acquired hypothal...
Analyst ratings
94%
of 16 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.